Sponsor:
David Bartlett, MD
Code:
NCT07192900
Conditions
Malignant Pleural Effusion
Malignant Mesothelioma
Pleural Effusion, Malignant
Metastasis to Pleura
Eligibility Criteria
Sex: All
Age: 18 - 70+
Healthy Volunteers: Not accepted
Interventions
locally manufactured adoptive cellular therapy (ACT) product
Interleukin-2
Study Details
Eligibility Criteria
Study Design
Interventions and Outcome Measures
Central Contacts and Locations
More Information
Trial information was received from ClinicalTrials.gov and was last updated on 2026-02-13. This information was provided to ClinicalTrials.gov by David Bartlett, MD on 2026-01-15.